Pages that link to "Q71523105"
Jump to navigation
Jump to search
The following pages link to Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in patients with stable chronic heart failure (Q71523105):
Displaying 8 items.
- Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat (Q25257437) (← links)
- Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update (Q34585090) (← links)
- Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure (Q34634131) (← links)
- Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients (Q35803026) (← links)
- ACE inhibitors in pediatric patients with heart failure (Q36403677) (← links)
- High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril (Q48326616) (← links)
- Effect of imidapril and nifedipine on left ventricular hypertrophy in untreated hypertension. (Q53569668) (← links)
- Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group (Q73321612) (← links)